Bevicort
- Beviprex inhaler is specifically designed to maintain COPD, targeting chronic bronchitis and emphysema symptoms.
- It blends micronized Budesonide, Glycopyrrolate, and Formoterol Fumarate, effectively reducing lung inflammation and promoting bronchodilation.
- The recommended dosage involves two inhalations twice daily, offering a convenient regimen for COPD management.
- With its comprehensive approach, Beviprex aims to improve respiratory health and enhance the quality of life for COPD patients.
